Takeda and Frazier announced a collaboration to launch HilleVax, Inc, a biopharmaceutical company, to develop and commercialize Takeda’s norovirus vaccine candidate
Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners announced a collaboration to launch HilleVax, Inc, a biopharmaceutical company, to develop and commercialize... Read More
Case Insight: Piramal Pharma’s acquisition of Hemmo Pharmaceuticals
Piramal Pharma Ltd has completed the acquisition of Hemmo Pharmaceuticals. In March this year, Piramal Pharma Ltd entered into an agreement to... Read More
Rossari Biotech to acquire Tristar Intermediates
Rossari Biotech Ltd, a speciality chemicals manufacturer, on Sunday announced the acquisition of Tristar Intermediates at an enterprise value of Rs 120... Read More
FDA Grants Accelerated Approval for Alzheimer’s drug Aduhelm
Posted on10 Jun 2021
Tagsaducanumab, Aduhelm, Biogen, Eisai, global pharma licensing deal, monoclonal antibody, Neurimmune, pharma deal
Comments0
USFDA approved Aduhelm (aducanumab) for the treatment of Alzheimer disease. Alzheimer’s drug Aduhelm is research molecule of Neurimmune. Neurimmune licensed its antibody... Read More
Insight on Neurogastrx licensing deal with Daewoong Pharmaceutical to Develop Fexuprazan
Neurogastrx, Inc. has entered into an exclusive license agreement with Daewoong Pharmaceutical Co., Ltd., of Seoul, South Korea, for the development and... Read More
Corbus Pharma in-licenses two integrin targeting MAbs
US biotech Corbus Pharmaceuticals (Nasdaq: CRBP) today announced the expansion of its portfolio into immuno-oncology through licensing deals for two new monoclonal... Read More
Case Study: Strategic Insight of acquisition of Constellation Pharmaceuticals by MorphoSys
Posted on03 Jun 2021
TagsConstellation Pharmaceuticals, MorphoSys AG, pharma deal, pharma strategic deal, strategic management in pharma
Comments0
MorphoSys AG, and Constellation Pharmaceuticals, Inc. announced that they have entered into a definitive agreement whereby MorphoSys will acquire Constellation for $34.00... Read More
Insight on Sun Pharma’s Licensing Agreement with Ferring Pharmaceutical for Caritec in India
Sun Pharmaceutical Industries entered into a licensing agreement with Ferring Pharmaceuticals to commercialise innovative obstetric drug Caritec in India. One of the... Read More
Case Study: Pfizer acquires Amplyx Pharmaceuticals
Pfizer has bought privately held Amplyx Pharmaceuticals for an undisclosed sum, gaining experimental antifungal and antiviral treatments as the world’s attention turns... Read More
Insight on why Jazz Pharmaceuticals to acquire GW Pharma?
GW Pharmaceuticals announced they have entered into an agreement with Jazz Pharmaceutical. As per the agreement, Jazz to acquire GW Pharma. Both... Read More